CY1108832T1 - Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα - Google Patents

Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα

Info

Publication number
CY1108832T1
CY1108832T1 CY20091100230T CY091100230T CY1108832T1 CY 1108832 T1 CY1108832 T1 CY 1108832T1 CY 20091100230 T CY20091100230 T CY 20091100230T CY 091100230 T CY091100230 T CY 091100230T CY 1108832 T1 CY1108832 T1 CY 1108832T1
Authority
CY
Cyprus
Prior art keywords
active substance
patch
pharmaceutical
skin
features above
Prior art date
Application number
CY20091100230T
Other languages
Greek (el)
English (en)
Inventor
Stefan Bracht
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33154271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108832(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of CY1108832T1 publication Critical patent/CY1108832T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Materials For Medical Uses (AREA)
CY20091100230T 2003-04-17 2009-02-27 Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα CY1108832T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10317692A DE10317692A1 (de) 2003-04-17 2003-04-17 Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
EP04726478A EP1615628B1 (de) 2003-04-17 2004-04-08 Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut

Publications (1)

Publication Number Publication Date
CY1108832T1 true CY1108832T1 (el) 2014-07-02

Family

ID=33154271

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100230T CY1108832T1 (el) 2003-04-17 2009-02-27 Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα

Country Status (22)

Country Link
US (3) US10653636B2 (enExample)
EP (1) EP1615628B1 (enExample)
JP (2) JP5733875B2 (enExample)
KR (1) KR101052127B1 (enExample)
CN (1) CN100450472C (enExample)
AT (1) ATE415954T1 (enExample)
AU (1) AU2004229159B2 (enExample)
BR (1) BRPI0409889B8 (enExample)
CA (1) CA2522962C (enExample)
CY (1) CY1108832T1 (enExample)
DE (2) DE10317692A1 (enExample)
DK (1) DK1615628T3 (enExample)
ES (1) ES2320550T3 (enExample)
IL (1) IL171399A (enExample)
MX (1) MXPA05010935A (enExample)
NZ (1) NZ543195A (enExample)
PL (1) PL1615628T3 (enExample)
PT (1) PT1615628E (enExample)
RU (1) RU2336866C2 (enExample)
SI (1) SI1615628T1 (enExample)
WO (1) WO2004091590A1 (enExample)
ZA (1) ZA200507034B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
RU2367577C1 (ru) 2005-08-12 2009-09-20 Рик Б. ЙЕГЕР Система и способ для нанесения изменяющего отражательную способность вещества в целях улучшения визуальной привлекательности человеческой кожи
US8942775B2 (en) 2006-08-14 2015-01-27 Tcms Transparent Beauty Llc Handheld apparatus and method for the automated application of cosmetics and other substances
US8184901B2 (en) 2007-02-12 2012-05-22 Tcms Transparent Beauty Llc System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image
JP5237112B2 (ja) * 2006-12-01 2013-07-17 日東電工株式会社 経皮吸収製剤
KR101408454B1 (ko) * 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 착색을 억제하는 방법 및 도네페질의 친척 물질의 생성량을 감소시키는 방법
JP2010519185A (ja) 2007-02-12 2010-06-03 リック ビー. イェーガー, 作用物質を静電気的に人の皮膚に塗布するためのシステムおよび方法
US10092082B2 (en) 2007-05-29 2018-10-09 Tcms Transparent Beauty Llc Apparatus and method for the precision application of cosmetics
RU2483729C2 (ru) * 2008-05-30 2013-06-10 Нитто Денко Корпорейшн Чрескожно абсорбируемый препарат
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
EP3310327A2 (en) * 2015-06-22 2018-04-25 Johnson & Johnson Consumer Inc. Method for providing a benefit to skin
JP7398750B2 (ja) * 2019-02-28 2023-12-15 パナソニックIpマネジメント株式会社 画像処理装置、画像処理方法およびシート

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE7529365U (de) 1976-01-08 Beiersdorf Ag, 2000 Hamburg Wund schnell verband
JPS55111416A (en) * 1979-02-20 1980-08-28 Taisho Pharmaceut Co Ltd Paster
US4594276A (en) * 1984-04-09 1986-06-10 Minnesota Mining And Manufacturing Company Printed, removable body tattoos on a translucent substrate
JPH0739566B2 (ja) 1986-02-21 1995-05-01 積水化学工業株式会社 医療用粘着テープもしくはシートの製造方法
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5004510A (en) * 1989-01-30 1991-04-02 Panzhihua Iron & Steel Co. Process for manufacturing high strength railroad rails
DE4030465C2 (de) * 1990-09-26 1994-06-01 Ruschke Mona Pflaster
US5120325A (en) * 1991-06-12 1992-06-09 Fleshtones Products Co., Inc. Color-matched sterile adhesive bandages containing melanin-like pigment composition
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing
JPH07206624A (ja) 1994-01-20 1995-08-08 Shiseido Co Ltd 皮膚外用剤
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
DE19519593C1 (de) * 1995-05-29 1996-08-29 Horstmann Michael Transdermales Therapeutisches System mit druckfarbenfreier Identifikation und Verfahren zu seiner Herstellung
TR199802659T2 (xx) * 1996-06-20 1999-03-22 Lavipharm S.A. Topikal akne tedavisi i�in bir ara� ve tedavi y�ntemi.
US6025535A (en) * 1996-10-28 2000-02-15 The Procter & Gamble Company Topsheet for absorbent articles exhibiting improved masking properties
JPH11116470A (ja) * 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
HUP0104728A3 (en) * 1998-12-18 2006-07-28 Alza Corp Mountain View Transparent transdermal nicotine delivery device
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
AU2000242314B2 (en) * 2000-04-12 2005-11-03 The Procter & Gamble Company Pre-formed sheet devices suitable for topical application
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US8586079B2 (en) * 2002-06-21 2013-11-19 Graphic Productions Inc. Promotional simulation for transdermal patch sampler
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut

Also Published As

Publication number Publication date
ATE415954T1 (de) 2008-12-15
JP2012092133A (ja) 2012-05-17
JP5733875B2 (ja) 2015-06-10
AU2004229159B2 (en) 2010-01-28
JP2006523637A (ja) 2006-10-19
EP1615628B1 (de) 2008-12-03
US20190160017A1 (en) 2019-05-30
BRPI0409889A (pt) 2006-05-23
AU2004229159A1 (en) 2004-10-28
BRPI0409889B1 (pt) 2019-12-17
US10646453B2 (en) 2020-05-12
EP1615628A1 (de) 2006-01-18
DK1615628T3 (da) 2009-04-06
IL171399A (en) 2015-02-26
CA2522962A1 (en) 2004-10-28
MXPA05010935A (es) 2005-11-25
US20200206147A1 (en) 2020-07-02
HK1079455A1 (zh) 2006-04-07
CN100450472C (zh) 2009-01-14
KR101052127B1 (ko) 2011-07-26
ZA200507034B (en) 2006-05-31
PT1615628E (pt) 2009-03-11
PL1615628T3 (pl) 2009-06-30
KR20050114724A (ko) 2005-12-06
RU2336866C2 (ru) 2008-10-27
CA2522962C (en) 2011-11-01
DE10317692A1 (de) 2004-11-11
US20070116751A1 (en) 2007-05-24
US10653636B2 (en) 2020-05-19
NZ543195A (en) 2009-04-30
US11426358B2 (en) 2022-08-30
ES2320550T3 (es) 2009-05-25
RU2005129528A (ru) 2006-05-10
DE502004008582D1 (de) 2009-01-15
WO2004091590A1 (de) 2004-10-28
BRPI0409889B8 (pt) 2021-05-25
SI1615628T1 (sl) 2009-04-30
CN1826103A (zh) 2006-08-30

Similar Documents

Publication Publication Date Title
BR0215564A (pt) Composições tópicas para a pele e/ou cabelo que contêm uma proteìna hidrolisada
BRPI0517237A (pt) artigo absorvente descartável apresentando sinais visìveis
MX2021010988A (es) Derivados de insulina sensibles a la glucosa.
CY1107284T1 (el) Τσιροτο για την θεραπεια δυσλειτουργιων και διαταραχων της αυξησης των νυχιων
CY1111402T1 (el) Φαρμακο για τη θεραπεια της οστεονεκρωσης και για τη διαχειριση ασθενων μεκινδυνο εμφανισης οστεονεκρωσης
CY1106411T1 (el) Διαδepμικο θepαπευτικο συστημα με fentanyl
CO5040037A1 (es) Ropa medica con areas impresas regionalmente
BRPI0519242A2 (pt) uso derivados de 1-aminociclohexano para o tratamento de esclerose méltipla, instabilidade emocional e paralisia pseudobulbar
ATE353655T1 (de) Myo-inositol hexaphosphat zur topischen verwendung
AR043248A1 (es) Sistema terapeutico transdermico estable a los rayos uv
BR0215404A (pt) processo e dispositivo para reduzir dosagem terapêutica
DK1615628T3 (da) Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden
CY1111902T1 (el) Χρηση ακυλοφωσφοχολινων σε συνδυασμο με αντινεοπλασματικα φαρμακα
AR050621A1 (es) Sistema terapeutico transdermal con una capa adherente procedimiento para el siliconado de una capa de respaldo y empleo de la capa de respaldo
ATE429908T1 (de) Hormonhaltiges transdermales therapeutisches system mit einem wirkstoffreservoir auf der basis von vinylacetat-vinylpyrrolidon-copolymer mit verbesserter kohäsion.
ES2177783T3 (es) Uso de la gabapentina y sus derivados en el tratamiento de mania y desorden bipolar.
ES2182365T3 (es) Una pelicula de plastico para uso en agricultura.
ECSP055823A (es) DERIVADOS DE [6,7-DIHIDRO-5H-IMIDAZO[1,2-a]IMIDAZOL-3-SULFONILAMINO]-PROPIONAMIDA
ES2065634T3 (es) Composicion cosmetica o farmaceutica para el tratamiento de los cabellos y del cuero cabelludo.
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
ATE445393T1 (de) Tablette mit gefärbtem kern
ATE447978T1 (de) Kompresse für die kombinierte applikation von naturheilstoffen und elektromagnetischen strahlungen
ES2606340T3 (es) Cuero sintético con alta reflectancia de radiación infrarroja
ES2504365T3 (es) La actividad neuroprotectora de la proteína C activada es independiente de su actividad anticoagulante
CN309095201S (zh) 人体感应夜灯